Diabetes drugs GLP-1RA and SGLT2i lower dementia risk in older adults, study finds

	Diabetes
	The latest diabetes news from News Medical

	Diabetes drugs GLP-1RA and SGLT2i lower dementia risk in older adults, study finds A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of glucose-lowering drugs used in type 2 diabetes, were associated with a significantly reduced risk of Alzheimer’s disease and related dementias (ADRD). These findings suggest potential neuroprotective benefits and highlight drug repurposing as a promising strategy for ADRD prevention.

	GLP1 agonists linked to depression risk in new genetic study A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely used in blockbuster drugs like Ozempic-and the risk of depression and suicidal ideation (SI).

			Diabetes medications may help shield the brain from cognitive decline A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of Alzheimer's disease and related dementias in patients with Type 2 diabetes.

			New noninvasive method for early diabetes risk detection The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes risk early and spare you a needle prick or two.

			DASH diet and salt reduction work together to reduce cardiovascular risk Reducing dietary sodium and following the DASH diet each lower 10-year risk of atherosclerotic cardiovascular disease, with the greatest benefit when combined. This effect is especially strong for women, Black adults, and those with stage 2 hypertension.

	Study explores how Adapted Argentine tango dance therapy can help breast cancer survivors Adapted Argentine tango dance therapy is helping some breast cancer survivors regain natural balance and sensation after experiencing neuropathy, a common side effect of chemotherapy treatment.

	Reversing adipose tissue fibrosis through targeted microRNA therapies A new review published in Genes & Diseases highlights the transformative role of microRNAs (miRNAs) in regulating and potentially reversing adipose tissue fibrosis, a condition closely linked to obesity, diabetes, and cardiovascular disease.

	Insurance instability more common among low-income adults with diabetes An Oregon Health & Science University-led study reveals that low-income adults with diabetes are more likely to go in and out of health insurance, and that insurance instability is even worse for those with complex needs.

	New $15 million study aims to understand cardiovascular and kidney disease risk factors in women Research teams from Augusta University, Massachusetts General Hospital and The Ohio State University will lead a $15 million project dedicated to studying the various ways that risk factors for cardiovascular and kidney diseases impact women.

	Monell study offers renewed hope for people living with Bardet-Biedl Syndrome A Monell Chemical Senses Center study published this week in the Journal of Clinical Investigation offers renewed hope for individuals living with Bardet-Biedl Syndrome (BBS), a rare genetic disorder characterized by early-onset obesity, compulsive eating, and cognitive impairments.

	Is Seed Cycling Legit for Hormone Balance? Investigate the role of seed cycling in women's health, particularly its effects on hormonal regulation and PCOS symptom management through dietary practices.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025